| +0.45 / +1.43%|
The 7 analysts offering 12-month price forecasts for Sagent Pharmaceuticals Inc have a median target of 33.00, with a high estimate of 36.00 and a low estimate of 27.00. The median estimate represents a +3.45% increase from the last price of 31.90.
The current consensus among 8 polled investment analysts is to Hold stock in Sagent Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.